Catalyst Wire Dossier Catalyst Wire Dossier

YZJ-1139 Tablets

YZJ-1139 · Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YZJ-1139 Tablets, covering 2024-11-04 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets [Phase 1]

See pricing